Original Research
Kathryn Fitch, RN, MEd
;
Warner Huh, MD
;
Andrew Bochner, ASA, MAAA
Inpatient open hysterectomies have statistically significantly higher average allowed costs than outpatient laparoscopic, laparoscopic assisted, and vaginal hysterectomies and statistically significantly higher readmission rates than outpatient laparoscopic and laparoscopic-assisted hysterectomies.
News & Commentary
The U.S. Preventive Services Task Force (USPSTF) notes that the evidence for pelvic exams is actually pretty thin despite their time-honored place in the health care of American women. Only eight studies evaluating them have been done over the past 60 years, according to USPSTF research.
MediMedia Research Survey: Women’s Health Issues
When asked to rank the top five most important issues in women’s health, 40% of respondents ranked access to contraceptives as the number one issue, 31% ranked access to abortion services, and 28%, cancer screening. Seventy-eight percent thought that healthy aging will be the most important issue in three to five years.
Legislation & Regulation: Campaign 2016
Richard Mark Kirkner

Paul Ryan

But the centerpiece of Ryan’s proposal—tax credits for everyone who needs to purchase individual policies regardless of income—may not go far enough to prevent people from losing coverage while creating new spending that would benefit high-income earners who can already buy their own health insurance.
Jan Greene
By some accounts, pregnancy and delivery is the single most expensive group of diagnoses for employers providing insurance coverage. Contraception coverage is in the ACA and it’s a good deal for insurers because contraception prevents unintended pregnancies. But complaints about limited options abound.
Susan Ladika
Guideline writers are dialing back breast screening recommendations because of concerns about false positives and overdiagnoses. For instance, there’s the debate about at what age screening should start. Meanwhile, advocates and some clinicians are pulling in the opposite direction—for more coverage, especially for 3D mammography.
Viewpoint
Richard G. Stefanacci, DO
;
Donald Ohioma, MS
Perhaps ACOs may be the answer to striking the right balance between utilization and clinical outcomes. But there’s a problem. They are not responsible for the costs of drugs covered by Medicare Part D plans in their total cost of care, but they are responsible for the costs of negative outcomes if medical treatment is inadequate or goes awry.
Value-Based Care
Frank Diamond

Harvey Kaufman, MD
Quest Diagnostics

Doctors maintain that they simply do not have all the tools they need to make value-based care happen, even if they wanted it to happen. Health insurance executives counter that the situation is not that bad. There’s some agreement, however, about quality measures being too complex.
Jack McCain
Long-lasting reversible contraceptives (LARCs) are easy to use and effective. One reason the U.S. lags behind other developed countries in LARC use is that memories of the Dalkon Shield still linger from the 1970s, when a design defect in that IUD resulted in infections that led to infertility, ectopic pregnancies, and death.